Ticker
YMABCompany Name
Y-MABS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 91.79M | $ 22.95M | $ 68.84M |
3/31/2025 | $ 90.45M | $ 18.96M | $ 71.49M |
12/31/2024 | $ 98.51M | $ 23.7M | $ 74.81M |
9/30/2024 | $ 99.06M | $ 25.29M | $ 73.77M |
6/30/2024 | $ 126.76M | $ 43.47M | $ 83.29M |
3/31/2024 | $ 108.27M | $ 17.61M | $ 90.66M |
12/31/2023 | $ 111.11M | $ 20.13M | $ 90.98M |
9/30/2023 | $ 114.86M | $ 21.81M | $ 93.05M |
6/30/2023 | $ 115.78M | $ 24.23M | $ 91.55M |
3/31/2023 | $ 124.01M | $ 25.92M | $ 98.09M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for Y-MABS THERAPEUTICS INC is calculated as follows: AssetsC [ $ 133.21M ] - LiabilitesC [ $ 19.78M ]
(=) Working Capital [ $ 113.43M ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 2.79K |
---|---|
min | $ -457.39M |
max | $ 607.04M |
average | $ 96.42M |
median | $ 32.11M |
std | $ 173.65M |